SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-011189
Filing Date
2017-11-08
Accepted
2017-11-08 16:11:40
Documents
53
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-093017x10q.htm 10-Q 620650
2 EXHIBIT 31.1 exhibit31-1q32017.htm EX-31.1 12305
3 EXHIBIT 31.2 exhibit31-2q32017.htm EX-31.2 12307
4 EXHIBIT 32.1 exhibit32-1q32017.htm EX-32.1 4928
5 EXHIBIT 32.2 exhibit32-2q32017.htm EX-32.2 4170
  Complete submission text file 0001628280-17-011189.txt   3560631

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mgnx-20170930.xml EX-101.INS 685929
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20170930.xsd EX-101.SCH 31562
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20170930_cal.xml EX-101.CAL 55497
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20170930_def.xml EX-101.DEF 114241
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20170930_lab.xml EX-101.LAB 409272
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20170930_pre.xml EX-101.PRE 234118
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 171186724
SIC: 2834 Pharmaceutical Preparations